Financial reports
10-K/A
2014 FY
Annual report (amended)
30 Jun 14
10-K
2014 FY
Annual report
30 May 14
10-Q
2014 Q3
Quarterly report
6 Feb 14
10-Q
2014 Q2
Quarterly report
7 Nov 13
10-Q
2014 Q1
Quarterly report
7 Aug 13
ARS
2013 FY
Annual report to shareholders
11 Jul 13
10-K/A
2013 FY
Annual report (amended)
13 Jun 13
10-K
2013 FY
Annual report
23 May 13
10-Q
2013 Q3
Quarterly report
7 Feb 13
10-Q
2013 Q2
Quarterly report
9 Nov 12
Current reports
8-K
Actavis Completes Forest Laboratories Acquisition
3 Jul 14
8-K
Actavis Completes Acquisition of Furiex Pharmaceuticals
3 Jul 14
8-K
Entry into a Material Definitive Agreement
3 Jul 14
8-K
Actavis and Forest Shareholders Approve Proposals Related to Actavis’ Planned Acquisition of Forest
18 Jun 14
8-K
Forest Laboratories, Inc. Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Certain of its Senior Notes
13 Jun 14
8-K
Other Events
9 Jun 14
8-K
Other Events
29 May 14
8-K
Forest Laboratories, Inc. Commences Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes
22 May 14
8-K
Departure of Directors or Certain Officers
20 May 14
8-K
Forest Laboratories, Inc. Reports
29 Apr 14
Registration and prospectus
15-12B
Securities registration termination
15 Jul 14
25-NSE
Exchange delisting
2 Jul 14
POS AM
Prospectus update (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Jul 14
Proxies
DEFM14A
Proxy related to merger
6 May 14
DFAN14A
Additional proxy materials by non-management
30 Apr 14
DEFA14A
Additional proxy soliciting materials
29 Apr 14
DEFA14A
Additional proxy soliciting materials
28 Apr 14
DEFA14A
Additional proxy soliciting materials
9 Aug 13
DEFA14A
Additional proxy soliciting materials
22 Jul 13
DEF 14A
Definitive proxy
8 Jul 13
DEFA14A
Additional proxy soliciting materials
11 Jun 13
DEFA14A
Additional proxy soliciting materials
13 Aug 12
DFAN14A
Additional proxy materials by non-management
13 Aug 12
Other
EFFECT
Notice of effectiveness
7 Jul 14
CT ORDER
Confidential treatment order
2 Apr 14
UPLOAD
Letter from SEC
25 Mar 14
CORRESP
Correspondence with SEC
28 Feb 14
CORRESP
Correspondence with SEC
12 Feb 14
UPLOAD
Letter from SEC
31 Jan 14
CT ORDER
Confidential treatment order
2 Aug 13
CT ORDER
Confidential treatment order
20 Jun 13
CT ORDER
Confidential treatment order
9 Oct 12
CERTNYS
Certification of approval for NYSE listing
6 Sep 12
Ownership
SC 13G/A
Forest Laboratories, LLC
10 Jul 14
SC 13D/A
Furiex Pharmaceuticals, Inc.
9 Jul 14
SC 13D/A
Forest Laboratories, LLC
1 Jul 14
SC 13G/A
Forest Laboratories Inc
10 Jun 14
SC 13D
Furiex Pharmaceuticals, Inc.
6 May 14
SC 13G/A
Forest Laboratories Inc
14 Feb 14
SC 13G/A
Forest Laboratories Inc
14 Feb 14
SC 13G/A
Forest Laboratories Inc
13 Feb 14
SC 13G/A
Forest Laboratories Inc
11 Feb 14
SC 13G/A
Forest Laboratories Inc
4 Feb 14